Lachesis Biosciences

Lachesis Biosciences Lachesis Biosciences is a development company focused on nasal spray and nasal absorption technology. Lachesis Biosciences clinical-stage, Rivastigmine Nasal Spray product candidate is for the treatment of dementia symptoms associated with Alzheimer’s and Parkinson’s diseases.

 
 

News

Lachesis Biosciences Limited ASX Initial Public Offer - Prospectus and Application

🕔9/15/2016 5:25:33 PM 6519

Lachesis Biosciences Limited are pleased to provide a Prospectus to raise up to $6,000,000 by an Offer to the public comprising: Offer of 5,000,000 New Shares at an issue price of $1.00 each totaling $5,000,000; and Oversubscriptions of up to a maximum of $1,000,000.

Read Full Article
###

2,081 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 21) (Since Published: 2081) 

Company Data

    Headquarters
  • Level 19, 15 William Street
    Melbourne VIC 3000 Australia
  • Telephone
  • +61-3-5561-7758 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.lachesisbio.com.au
  • E:
  • partnering@lachesisbio.com.au